封面
市場調查報告書
商品編碼
1516096

骨空隙填充劑市場 - 按材料類型、形式、應用、最終用途 - 全球預測

Bone Void Fillers Market - By Material Type, Form, Application, End-use - Global Forecast

出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於骨科疾病和骨骼相關疾病(如骨質疏鬆症、關節炎和骨折)盛行率不斷上升,骨空隙填充劑市場規模預計從 2024 年到 2032 年複合年成長率將達到創紀錄的 6.8%。根據世界衛生組織的數據,全世界約有 3.5 億人患有某種關節炎。容易發生骨質流失和骨折的老年人數量不斷增加,需要有效的骨科植入物來促進癒合。醫療技術的進步有助於開發更複雜的生物相容性材料,以增強骨骼再生和整合。

由於創傷和運動傷害而增加的外科手術也將推動市場成長。隨著人們參與體育運動和高強度運動的增多,需要手術干預並進行骨填充的骨科病變的發生率也會激增。新興國家為擴大先進骨科手術的可用性而不斷增加的政府支持政策和不斷增加的醫療保健支出將有利於產品需求。骨空隙填充劑產業分為材料類型、形式、應用、最終用途和區域。

根據材料類型,由於其卓越的生物相容性、可吸收性和臨床環境中的易用性,硫酸鈣細分市場的市場佔有率將在 2024 年至 2032 年間錄得可觀的成長率。硫酸鈣是新骨生長的良好支架,可在自然骨再生時提供暫時性回縮支撐,從而減少第二次手術去除填充物的需要。涵蓋骨科、牙科和臉部手術的多功能性優勢將推動產品需求。

顆粒形式的骨空隙填充劑產業預計在 2024 年至 2032 年期間將顯著成長,原因是其多功能性、易於使用以及促進骨再生的有效性。顆粒提供了可客製化的解決方案,用於填充不同形狀和尺寸的骨缺損,使其成為各種骨科和牙科治療的理想選擇。這些顆粒具有允許血管滲透並促進成骨細胞遷移的多孔結構,對於新骨的形成至關重要。

到 2032 年,亞太地區骨空隙填充劑產業規模將大幅成長,原因是醫療基礎設施和支出不斷擴大,以及人口老化導致骨相關疾病盛行率上升。中國和印度的快速城市化和工業化導致受傷率上升,進一步推動了對有效骨科修復解決方案的需求。不斷成長的醫療旅遊業,特別是在泰國和馬來西亞,以實惠的成本提供先進的骨科服務並吸引國際患者,將促進該地區市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 骨骼疾病和損傷的發生率增加
      • 老年人口增加
      • 手術技術的進步
      • 日益成長的骨科手術
    • 產業陷阱與挑戰
      • 與骨骼疾病相關的高成本
      • 嚴格的監管場景
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按材料類型,2021 - 2032 年

  • 主要趨勢
  • 去礦骨基質
  • 硫酸鈣
  • 膠原蛋白基質
  • 磷酸三鈣
  • 其他材料類型

第 6 章:市場估計與預測:按形式,2021 - 2032

  • 主要趨勢
  • 凝膠
  • 顆粒劑
  • 貼上
  • 油灰
  • 其他形式

第 7 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 脊椎融合
  • 骨折
  • 關節重建
  • 其他應用

第 8 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 骨科診所
  • 門診手術中心
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • Abyrx, Inc.
  • Baxter International Inc.
  • Bioventus Inc.
  • BONESUPPORT HOLDING AB
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Medtronic plc
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.
簡介目錄
Product Code: 8861

Bone void fillers market size is set to record 6.8% CAGR from 2024 to 2032, driven by the rising prevalence of orthopedic conditions and bone-related diseases, such as osteoporosis, arthritis, and bone fractures. As per WHO, around 350 million people worldwide have some kind of arthritis. The rise in number of older individuals susceptible to bone mass loss and fractures is necessitating effective orthopedic implants to facilitate healing. Advancements in medical technology are helping in developing more sophisticated biologically compatible materials to enhance bone regeneration and integration.

Rising surgical procedures due to trauma and sports injuries will also drive the market growth. As participation in sports and high-impact exercise is increasing, the incidence of orthopedic lesions requiring surgical intervention followed by bone filling will also surge. Rising supportive government policies and the increasing healthcare expenditures in emerging countries for expanding the availability of advanced orthopedic procedures will favor the product demand. The bone void fillers industry is segmented into material type, form, application, end-use, and region.

Based on material type, the market share from the calcium sulfate segment will record a decent growth rate between 2024 and 2032 due to its exceptional biocompatibility, resorbability, and ease of use in clinical settings. Calcium sulfate acts as a good scaffold for new bone growth for providing temporary retraction support when natural bone regenerate, reducing the need for a second operation to remove the filling on. Benefits of versatility, covering orthopedic, dental, and facial surgery will drive the product demand.

Bone void fillers industry from the granules form segment is anticipated to witness significant growth through 2024-2032 driven by its versatility, ease of application, and effectiveness in promoting bone regeneration. Granules offer a customizable solution for filling bone defects of different shapes and sizes, making them ideal for a wide range of orthopedic and dental treatments. With porous structure that allows blood vessels to permeate and promote the migration of osteoblasts, these granules have grown critical for new bone formation.

Asia Pacific bone void fillers industry size will record substantial growth through 2032, attributed to expanding healthcare infrastructure and expenditure along with the rising prevalence of bone-related ailments due to aging population. Rapid urbanization and industrialization in China and India have led to increased injury rates, further driving the demand for effective orthopedic restorative solutions. The growing medical tourism industry, especially in Thailand and Malaysia for offering advanced orthopedic services at affordable costs and attracting international patients will add to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of bone disorders and injuries
      • 3.2.1.2 Rise in geriatric population
      • 3.2.1.3 Advancements in surgical techniques
      • 3.2.1.4 Growing orthopedic surgeries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with bone disorders
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Material Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Demineralized bone matrix
  • 5.3 Calcium sulfate
  • 5.4 Collagen matrix
  • 5.5 Tricalcium phosphate
  • 5.6 Other material types

Chapter 6 Market Estimates and Forecast, By Form, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Gel
  • 6.3 Granules
  • 6.4 Paste
  • 6.5 Putty
  • 6.6 Other forms

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Spine fusion
  • 7.3 Bone fracture
  • 7.4 Joint reconstruction
  • 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Orthopedic clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abyrx, Inc.
  • 10.2 Baxter International Inc.
  • 10.3 Bioventus Inc.
  • 10.4 BONESUPPORT HOLDING AB
  • 10.5 Johnson & Johnson
  • 10.6 Medline Industries, Inc.
  • 10.7 Medtronic plc
  • 10.8 Stryker Corporation
  • 10.9 Wright Medical Group N.V.
  • 10.10 Zimmer Biomet Holdings, Inc.